| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Financial Officer | Chief Financial Officer
1 company
Rodney Kb Young is Chief Financial Officer at RAPT. Rodney Kb Young's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider.
Rodney Kb Young has 10 Form 4 filings on record from December 2019 to March 2026, all as Chief Financial Officer at RAPT Therapeutics (RAPT), 2019–2026.
The 26 reported transactions were 12 dispositions back to the company, 12 option or other derivative awards, 1 tender and 1 open-market purchase.
Counted by filing, the open-market trades come to 1 purchase worth about $53K and no sales.
The only open-market purchase was 5,000 shares of RAPT at an average $10.53 on May 10, 2022, about $53K. Twelve months later RAPT was up 77%.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 10, 2022 | RAPT Rapt Therapeutics, Inc. | Chief Financial Officer | Buy | 5,000 | $10.53 | $52,650.00 | +98.3% | +95.7% | +77.4% |